KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Authorities in the Democratic Republic of the Congo have initiated a focused Ebola immunization campaign in Kisangani, the administrative center of Tshopo Province, aiming to halt the deadliest outbreak in the country’s history. Frontline healthcare providers, emergency responders, and those with direct contact to confirmed cases are receiving priority during the first phase of vaccination. Health Minister Roger Kamba confirmed the campaign employs doses of the Ervebo vaccine to protect essential personnel working across the eastern provinces most affected.
Official epidemiological reports reveal that the outbreak has now spread through six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Data from the Ministry of Public Health and Prevention show a total of 5,713 confirmed cases and 2,744 fatalities, with an overall case fatality rate around 48% among confirmed patients.
International health organizations, such as the World Health Organization, have stepped in to assist local teams with logistics, laboratory testing, and vaccine distribution efforts amidst the public health emergency. Vaccinations with Ervebo are being administered under a compassionate-use protocol while researchers gather observational data on its effectiveness against the region’s circulating strain. DR Congo advances its Ebola response by expanding ring-vaccination around identified infection clusters to contain transmission chains.
Ebola Vaccination Campaign Extends Through Multiple Eastern Provinces in DR Congo
Operational challenges include difficult regional infrastructure, ongoing security issues, and high population movement across border zones. Kisangani has set up cold-chain logistics to preserve the ultra-low temperatures necessary for vaccine storage before distribution to remote health districts. The government continues its Ebola vaccination campaign, with civil defense and community health workers conducting outreach to enhance disease surveillance and reporting efforts.
Epidemiologists from the Africa Centres for Disease Control and Prevention are collaborating with local teams to monitor adverse effects and assess immune responses in vaccinated groups. Early detection, isolation measures, and supportive care remain critical for improving survival chances, while additional vaccine shipments are planned as vaccination expands regionally across secondary districts.
Kisangani Acts as Central Hub for Regional Ebola Vaccine Distribution
Response teams are broadening contact tracing efforts in both urban and rural eastern areas. Local health centers are supplied with PPE, diagnostic reagents, and treatment supplies to bolster preparedness. The government affirms that public health measures will continue until transmission metrics show consistent decline across affected provinces.
Authorities urge communities to support mobile vaccination teams and follow sanitary guidelines. Increased immunization coverage among high-risk populations is expected to stabilize infection rates over the coming weeks, with surveillance intensified at transit hubs and border crossings to prevent further spread.